WHO Introduces Groundbreaking list of new medicines to Combat Multiple Infectious Diseases

▴ new medicine list
In a significant development, the World Health Organization (WHO) has recently released the 23rd edition of the Model Lists of Essential Medicines (EML) and the 9th edition of the Essential Medicines for Children (EMLc). These updated lists, published in July 2023, include notable additions of new medicines aimed at treating various health conditions, including multiple sclerosis, cancer, infectious diseases, and cardiovascular conditions.

The EML and EMLc serve as internationally recognized guides to assist countries' healthcare systems in prioritizing effective and affordable medications. Updated every two years, the WHO's new editions have expanded the total number of medications listed on the EML and EMLc to 502 and 361, respectively

Among the noteworthy additions to the 2023 list are three medications specifically designed to slow down the progression of multiple sclerosis (MS), a chronic nervous system disease that affects 2.8 million people worldwide One of these drugs, rituximab, which is typically used to treat certain cancers and autoimmune diseases, has been recommended for off-label use in treating MS due to its proven efficacy and safety

However, it is worth noting that despite requests from researchers in the world, obesity medications were not included in the list, the WHO committee rejected the application, citing the "uncertain long-term clinical benefit and safety in this patient population"

In an important milestone, the guidelines also recommend the use of "polypills" for the first time in the treatment of heart disease and other cardiovascular issues Polypills are combinations of medications that help lower blood pressure, reduce cholesterol, regulate heartbeat, and may even include aspirin. Research has shown that these polypills can reduce the risk of cardiovascular problems by nearly 40%

Similarly, risdiplam for treating spinal muscular atrophy, donepezil for the treatment of dementia due to Alzheimer's disease, CAR-T cell therapy for lymphoma, and fast-acting oral transmucosal fentanyl for breakthrough cancer pain were not included in the updated lists

The WHO's release of the new EML and EMLc editions is a significant step forward in improving healthcare access and addressing a range of health conditions worldwide. By including effective and affordable medications for multiple sclerosis, cancer, infectious diseases, and cardiovascular issues, the WHO aims to provide countries with crucial guidance for their healthcare systems.

This update underscores the importance of research and innovation in the field of medicine, as new treatments continue to emerge that can positively impact the lives of millions globally. With the introduction of these new medicines, healthcare providers and policymakers will have access to updated information to help them make informed decisions in selecting appropriate treatments for their patients.

Tags : #who #medicines #cancermedicines #2023list #2023medicines #whoupdates #hospitalupdates #healthnews #medicineupdates #worldhealthorganisation #doctorsupdates #pills #updates

Related Stories

Loading Please wait...


Trending Now

Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024